AMERIPRISE FINANCIAL INC

Position in ABSI — Absci Corp

CIK 820027 MINNEAPOLIS, MN

Position in ABSI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,540,423

-$1,615,629 QoQ

Shares Held

3,180,141

-0.5% QoQ

Ownership

2.04%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 98.60811203025276.ToString("F0")% None 1.3918879697472533.ToString("F0")%

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. ABSI ranks #51 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,633,481	$1,175,954,602
2	INSM	INSMED Inc	3,057,718	$499,998,043
3	JAZZ	Jazz Pharmaceuticals plc	1,608,476	$304,082,386
4	REGN	Regeneron Pharmaceuticals, Inc.	319,677	$246,995,233
5	ARGX	Argenx SE	215,910	$157,668,275
6	RVMD	Revolution Medicines, Inc.	1,579,793	$153,634,868
7	ASND	Ascendis Pharma A/S	476,466	$108,982,067
8	BBIO	BridgeBio Pharma, Inc.	1,248,521	$92,715,166

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,540,423	3,180,141	-0.5%	Shares	Defined	2026-05-15
2025-12-31	$11,156,052	3,196,577	+0.2%	Shares	Defined	2026-02-17
2025-09-30	$9,700,672	3,191,011	+24.4%	Shares	Defined	2025-11-14
2025-06-30	$6,593,487	2,565,560	-0.9%	Shares	Defined	2025-08-14
2025-03-31	$6,496,461	2,588,232	-0.3%	Shares	Defined	2025-05-14
2024-12-31	$6,801,922	2,596,154	-0.9%	Shares	Defined	2025-02-14
2024-09-30	$10,007,717	2,619,822	+1919.3%	Shares	Defined	2024-11-14
2024-06-30	$399,599	129,740	+5.1%	Shares	Defined	2024-08-14
2024-03-31	$701,480	123,500	-3.1%	Shares	Defined	2024-05-15
2023-12-31	$535,500	127,500	+46.6%	Shares	Defined	2024-02-14
2022-03-31	$732,946	86,945	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.